

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.60073838 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.55910331 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.50261878 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.50261878 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.23965090 |
| 6 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.03692967 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.80116648 |
| 8 | detection of other organism (GO:0098543) | 4.54437865 |
| 9 | interferon-gamma production (GO:0032609) | 4.44710673 |
| 10 | detection of bacterium (GO:0016045) | 4.42373729 |
| 11 | cellular extravasation (GO:0045123) | 4.35910818 |
| 12 | immunoglobulin mediated immune response (GO:0016064) | 4.27769213 |
| 13 | regulation of B cell differentiation (GO:0045577) | 4.25416324 |
| 14 | positive regulation of B cell differentiation (GO:0045579) | 4.13980529 |
| 15 | microglial cell activation (GO:0001774) | 4.11529818 |
| 16 | mast cell activation (GO:0045576) | 4.08867391 |
| 17 | neutrophil activation involved in immune response (GO:0002283) | 4.04632064 |
| 18 | negative regulation of phagocytosis (GO:0050765) | 4.03951039 |
| 19 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.94043446 |
| 20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.90718963 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.90718963 |
| 22 | modulation by symbiont of host immune response (GO:0052553) | 3.90718963 |
| 23 | positive regulation by symbiont of host defense response (GO:0052509) | 3.90718963 |
| 24 | modulation by symbiont of host defense response (GO:0052031) | 3.90718963 |
| 25 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.90718963 |
| 26 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.87863893 |
| 27 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.83959448 |
| 28 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.78764717 |
| 29 | B cell receptor signaling pathway (GO:0050853) | 3.73929562 |
| 30 | leukocyte aggregation (GO:0070486) | 3.73055712 |
| 31 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.72322027 |
| 32 | negative regulation of cell killing (GO:0031342) | 3.72322027 |
| 33 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.69265060 |
| 34 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.68694590 |
| 35 | detection of external biotic stimulus (GO:0098581) | 3.64015878 |
| 36 | positive T cell selection (GO:0043368) | 3.58893985 |
| 37 | negative regulation of T cell mediated immunity (GO:0002710) | 3.56258652 |
| 38 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.51691458 |
| 39 | ribosomal small subunit assembly (GO:0000028) | 3.47654153 |
| 40 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.45886568 |
| 41 | positive regulation of granulocyte differentiation (GO:0030854) | 3.43079726 |
| 42 | regulation of leukocyte degranulation (GO:0043300) | 3.39673395 |
| 43 | respiratory burst (GO:0045730) | 3.38230775 |
| 44 | positive regulation of antigen processing and presentation (GO:0002579) | 3.35286425 |
| 45 | B cell mediated immunity (GO:0019724) | 3.34914984 |
| 46 | T cell selection (GO:0045058) | 3.30380116 |
| 47 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.29872979 |
| 48 | negative regulation of interleukin-12 production (GO:0032695) | 3.29017402 |
| 49 | macrophage activation (GO:0042116) | 3.28986876 |
| 50 | detection of biotic stimulus (GO:0009595) | 3.28435475 |
| 51 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.28066359 |
| 52 | T cell migration (GO:0072678) | 3.26924631 |
| 53 | response to peptidoglycan (GO:0032494) | 3.25950454 |
| 54 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.25314362 |
| 55 | defense response to protozoan (GO:0042832) | 3.22686804 |
| 56 | actin nucleation (GO:0045010) | 3.20863362 |
| 57 | neutrophil activation (GO:0042119) | 3.20853917 |
| 58 | myeloid dendritic cell activation (GO:0001773) | 3.20100270 |
| 59 | response to protozoan (GO:0001562) | 3.19143510 |
| 60 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.18303374 |
| 61 | myeloid cell activation involved in immune response (GO:0002275) | 3.17643222 |
| 62 | positive regulation of mast cell degranulation (GO:0043306) | 3.17415722 |
| 63 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.15369501 |
| 64 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.15369501 |
| 65 | regulation of gamma-delta T cell activation (GO:0046643) | 3.15340393 |
| 66 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.10742114 |
| 67 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.10584764 |
| 68 | regulation of regulatory T cell differentiation (GO:0045589) | 3.10164487 |
| 69 | negative regulation of innate immune response (GO:0045824) | 3.10059579 |
| 70 | negative thymic T cell selection (GO:0045060) | 3.09481080 |
| 71 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.09330292 |
| 72 | cellular defense response (GO:0006968) | 3.09010748 |
| 73 | detection of molecule of bacterial origin (GO:0032490) | 3.08374840 |
| 74 | negative regulation of granulocyte differentiation (GO:0030853) | 3.06470923 |
| 75 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.06055122 |
| 76 | thymic T cell selection (GO:0045061) | 3.05669515 |
| 77 | regulation of mast cell activation (GO:0033003) | 3.04931172 |
| 78 | positive regulation of mast cell activation (GO:0033005) | 3.04444331 |
| 79 | regulation of tolerance induction (GO:0002643) | 3.03845365 |
| 80 | response to host (GO:0075136) | 3.03345713 |
| 81 | response to host defenses (GO:0052200) | 3.03345713 |
| 82 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.03345713 |
| 83 | activated T cell proliferation (GO:0050798) | 3.02111448 |
| 84 | germinal center formation (GO:0002467) | 2.98953957 |
| 85 | mast cell activation involved in immune response (GO:0002279) | 2.98568265 |
| 86 | mast cell degranulation (GO:0043303) | 2.98568265 |
| 87 | T cell homeostasis (GO:0043029) | 2.98230902 |
| 88 | cellular response to interferon-beta (GO:0035458) | 2.97626366 |
| 89 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.97443510 |
| 90 | response to muramyl dipeptide (GO:0032495) | 2.97306972 |
| 91 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.97052053 |
| 92 | megakaryocyte development (GO:0035855) | 2.95173150 |
| 93 | granulocyte activation (GO:0036230) | 2.94758625 |
| 94 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.94324267 |
| 95 | positive thymic T cell selection (GO:0045059) | 2.93971470 |
| 96 | positive regulation of isotype switching (GO:0045830) | 2.93368554 |
| 97 | regulation of mast cell degranulation (GO:0043304) | 2.93182837 |
| 98 | cellular response to exogenous dsRNA (GO:0071360) | 2.92932479 |
| 99 | regulation of antigen processing and presentation (GO:0002577) | 2.92401449 |
| 100 | negative T cell selection (GO:0043383) | 2.91506765 |
| 101 | dendritic cell migration (GO:0036336) | 2.90875450 |
| 102 | lymphoid progenitor cell differentiation (GO:0002320) | 2.89629055 |
| 103 | regulation of regulated secretory pathway (GO:1903305) | 2.89620253 |
| 104 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.89515842 |
| 105 | leukocyte cell-cell adhesion (GO:0007159) | 2.88260335 |
| 106 | dendritic cell chemotaxis (GO:0002407) | 2.87682128 |
| 107 | cell wall macromolecule catabolic process (GO:0016998) | 2.87452757 |
| 108 | positive regulation of interferon-alpha production (GO:0032727) | 2.86626997 |
| 109 | response to interferon-beta (GO:0035456) | 2.84924203 |
| 110 | type I interferon signaling pathway (GO:0060337) | 2.84362349 |
| 111 | cellular response to type I interferon (GO:0071357) | 2.84362349 |
| 112 | macrophage activation involved in immune response (GO:0002281) | 2.84339330 |
| 113 | response to interleukin-15 (GO:0070672) | 2.83751541 |
| 114 | regulation of T cell tolerance induction (GO:0002664) | 2.83688375 |
| 115 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.82065866 |
| 116 | leukocyte degranulation (GO:0043299) | 2.79123824 |
| 117 | pinocytosis (GO:0006907) | 2.78034961 |
| 118 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.75086480 |
| 119 | response to host immune response (GO:0052572) | 2.75086480 |
| 120 | cellular response to interleukin-15 (GO:0071350) | 2.74907980 |
| 121 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.73229743 |
| 122 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.72408550 |
| 123 | natural killer cell activation (GO:0030101) | 2.72200332 |
| 124 | mature B cell differentiation (GO:0002335) | 2.72140183 |
| 125 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.71819729 |
| 126 | positive regulation of defense response to virus by host (GO:0002230) | 2.70592005 |
| 127 | regulation of interferon-alpha production (GO:0032647) | 2.70164102 |
| 128 | neutrophil mediated immunity (GO:0002446) | 2.66691787 |
| 129 | angiogenesis involved in wound healing (GO:0060055) | 2.66553240 |
| 130 | myeloid leukocyte activation (GO:0002274) | 2.65249440 |
| 131 | mature B cell differentiation involved in immune response (GO:0002313) | 2.65215113 |
| 132 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.64087820 |
| 133 | positive regulation of T cell chemotaxis (GO:0010820) | 2.63936853 |
| 134 | regulation of T cell chemotaxis (GO:0010819) | 2.63936853 |
| 135 | myeloid dendritic cell differentiation (GO:0043011) | 2.63346151 |
| 136 | DNA deamination (GO:0045006) | 2.63029039 |
| 137 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.62720009 |
| 138 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.62404465 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.12787807 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.44819645 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.44397073 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.37723546 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.79272464 |
| 6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.71236082 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.58000668 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.52976393 |
| 9 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.12589593 |
| 10 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.09450919 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.08944225 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.04655244 |
| 13 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.96366273 |
| 14 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.85254975 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.74788657 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.74597416 |
| 17 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.63603813 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.62610802 |
| 19 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.60749118 |
| 20 | * MYB_26560356_Chip-Seq_TH2_Human | 2.56582910 |
| 21 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.55421273 |
| 22 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.53960560 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.39175793 |
| 24 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.26875752 |
| 25 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.25798506 |
| 26 | MYC_22102868_ChIP-Seq_BL_Human | 2.25740937 |
| 27 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.21265953 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.17284794 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.14950606 |
| 30 | * MAF_26560356_Chip-Seq_TH1_Human | 2.11038213 |
| 31 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.08620976 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.07588778 |
| 33 | MYB_26560356_Chip-Seq_TH1_Human | 2.06081045 |
| 34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.00153833 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.90804430 |
| 36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.87493027 |
| 37 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87287231 |
| 38 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83934028 |
| 39 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.82946034 |
| 40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.78888168 |
| 41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.77423979 |
| 42 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77003257 |
| 43 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.76911529 |
| 44 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.76555574 |
| 45 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75843057 |
| 46 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.73557929 |
| 47 | SPI1_23127762_ChIP-Seq_K562_Human | 1.67649372 |
| 48 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.59905971 |
| 49 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.58886693 |
| 50 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.56596201 |
| 51 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.54800475 |
| 52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.51228647 |
| 53 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.49535628 |
| 54 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.48090930 |
| 55 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.47110523 |
| 56 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.46982213 |
| 57 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.45787365 |
| 58 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.44384095 |
| 59 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.44005792 |
| 60 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.41608984 |
| 61 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.41322179 |
| 62 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.39899845 |
| 63 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.39896185 |
| 64 | GATA1_19941826_ChIP-Seq_K562_Human | 1.39790750 |
| 65 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.38729250 |
| 66 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.37094554 |
| 67 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.36486955 |
| 68 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.36171174 |
| 69 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.35440502 |
| 70 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33173457 |
| 71 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31268451 |
| 72 | MAF_26560356_Chip-Seq_TH2_Human | 1.27245338 |
| 73 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.25179010 |
| 74 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.22229117 |
| 75 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.21925325 |
| 76 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21831321 |
| 77 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19309537 |
| 78 | GATA3_26560356_Chip-Seq_TH2_Human | 1.12911918 |
| 79 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.12701734 |
| 80 | GATA2_19941826_ChIP-Seq_K562_Human | 1.12629932 |
| 81 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12119674 |
| 82 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11079486 |
| 83 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09113838 |
| 84 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.07842077 |
| 85 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05181820 |
| 86 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.04869308 |
| 87 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04016267 |
| 88 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.02967954 |
| 89 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.02202457 |
| 90 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01830242 |
| 91 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00604271 |
| 92 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.99793357 |
| 93 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.98643032 |
| 94 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.97664454 |
| 95 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.95123159 |
| 96 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95076820 |
| 97 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94401763 |
| 98 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93060653 |
| 99 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.92986658 |
| 100 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.91968236 |
| 101 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.87091573 |
| 102 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.86864392 |
| 103 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.84994780 |
| 104 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.84899838 |
| 105 | P300_27268052_Chip-Seq_Bcells_Human | 0.83496930 |
| 106 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.82576177 |
| 107 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.81680641 |
| 108 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.81585860 |
| 109 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.80509750 |
| 110 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.80146061 |
| 111 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.80088382 |
| 112 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78284910 |
| 113 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.77060439 |
| 114 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.76914053 |
| 115 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74105269 |
| 116 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.73546045 |
| 117 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.71878091 |
| 118 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.70462190 |
| 119 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.69630013 |
| 120 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.68841980 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.77783334 |
| 2 | MP0002396_abnormal_hematopoietic_system | 3.64546361 |
| 3 | MP0005671_abnormal_response_to | 3.61783234 |
| 4 | MP0009785_altered_susceptibility_to | 3.29640599 |
| 5 | MP0003436_decreased_susceptibility_to | 3.08593322 |
| 6 | MP0005025_abnormal_response_to | 3.03144094 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.99290990 |
| 8 | MP0001800_abnormal_humoral_immune | 2.97726264 |
| 9 | MP0002419_abnormal_innate_immunity | 2.89368656 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.88204811 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.80015585 |
| 12 | MP0001790_abnormal_immune_system | 2.77669310 |
| 13 | MP0005387_immune_system_phenotype | 2.77669310 |
| 14 | * MP0002420_abnormal_adaptive_immunity | 2.70431383 |
| 15 | MP0000685_abnormal_immune_system | 2.70260232 |
| 16 | * MP0001819_abnormal_immune_cell | 2.70247639 |
| 17 | MP0002723_abnormal_immune_serum | 2.68256855 |
| 18 | MP0002398_abnormal_bone_marrow | 2.35801875 |
| 19 | MP0006082_CNS_inflammation | 2.34337328 |
| 20 | MP0001853_heart_inflammation | 2.32997050 |
| 21 | MP0005464_abnormal_platelet_physiology | 2.26486426 |
| 22 | MP0003724_increased_susceptibility_to | 2.23807309 |
| 23 | MP0003763_abnormal_thymus_physiology | 2.23795047 |
| 24 | MP0002405_respiratory_system_inflammati | 2.21175940 |
| 25 | MP0003303_peritoneal_inflammation | 2.19426376 |
| 26 | MP0000716_abnormal_immune_system | 2.19059728 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 2.08216648 |
| 28 | MP0000689_abnormal_spleen_morphology | 2.01893828 |
| 29 | MP0005174_abnormal_tail_pigmentation | 1.96914065 |
| 30 | MP0002166_altered_tumor_susceptibility | 1.95479364 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.94280620 |
| 32 | MP0005397_hematopoietic_system_phenotyp | 1.91713169 |
| 33 | MP0001545_abnormal_hematopoietic_system | 1.91713169 |
| 34 | MP0002722_abnormal_immune_system | 1.91180597 |
| 35 | MP0002429_abnormal_blood_cell | 1.86790614 |
| 36 | MP0000465_gastrointestinal_hemorrhage | 1.85447519 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.82398193 |
| 38 | MP0002006_tumorigenesis | 1.79415140 |
| 39 | MP0000858_altered_metastatic_potential | 1.79252661 |
| 40 | MP0000490_abnormal_crypts_of | 1.76784159 |
| 41 | MP0004808_abnormal_hematopoietic_stem | 1.72757647 |
| 42 | MP0001873_stomach_inflammation | 1.66100853 |
| 43 | MP0009278_abnormal_bone_marrow | 1.62943156 |
| 44 | MP0003448_altered_tumor_morphology | 1.59703481 |
| 45 | MP0004947_skin_inflammation | 1.58553731 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.57928728 |
| 47 | MP0005075_abnormal_melanosome_morpholog | 1.54738051 |
| 48 | MP0004510_myositis | 1.54326677 |
| 49 | MP0000703_abnormal_thymus_morphology | 1.50544063 |
| 50 | MP0003300_gastrointestinal_ulcer | 1.50542195 |
| 51 | MP0003866_abnormal_defecation | 1.48430668 |
| 52 | MP0001533_abnormal_skeleton_physiology | 1.48353706 |
| 53 | MP0008469_abnormal_protein_level | 1.44900495 |
| 54 | MP0008260_abnormal_autophagy | 1.40461487 |
| 55 | MP0010307_abnormal_tumor_latency | 1.34953900 |
| 56 | MP0000343_altered_response_to | 1.33238507 |
| 57 | MP0002933_joint_inflammation | 1.33105484 |
| 58 | MP0003183_abnormal_peptide_metabolism | 1.31906939 |
| 59 | MP0008057_abnormal_DNA_replication | 1.28694049 |
| 60 | MP0005058_abnormal_lysosome_morphology | 1.27508721 |
| 61 | MP0003806_abnormal_nucleotide_metabolis | 1.19098801 |
| 62 | MP0009764_decreased_sensitivity_to | 1.16200436 |
| 63 | MP0003690_abnormal_glial_cell | 1.16148724 |
| 64 | MP0002019_abnormal_tumor_incidence | 1.13272488 |
| 65 | MP0001986_abnormal_taste_sensitivity | 1.11913414 |
| 66 | MP0010094_abnormal_chromosome_stability | 1.11625374 |
| 67 | MP0005310_abnormal_salivary_gland | 1.10025740 |
| 68 | MP0010352_gastrointestinal_tract_polyps | 1.03219221 |
| 69 | MP0001851_eye_inflammation | 1.02142562 |
| 70 | MP0008004_abnormal_stomach_pH | 0.99536860 |
| 71 | MP0002132_abnormal_respiratory_system | 0.99303365 |
| 72 | MP0003075_altered_response_to | 0.98851797 |
| 73 | MP0003693_abnormal_embryo_hatching | 0.98626383 |
| 74 | MP0002095_abnormal_skin_pigmentation | 0.91453128 |
| 75 | MP0004381_abnormal_hair_follicle | 0.90770997 |
| 76 | MP0002998_abnormal_bone_remodeling | 0.89946690 |
| 77 | MP0008007_abnormal_cellular_replicative | 0.88613410 |
| 78 | MP0009763_increased_sensitivity_to | 0.87648311 |
| 79 | MP0003787_abnormal_imprinting | 0.86879561 |
| 80 | MP0005164_abnormal_response_to | 0.84408869 |
| 81 | MP0005166_decreased_susceptibility_to | 0.83077968 |
| 82 | MP0002277_abnormal_respiratory_mucosa | 0.82526412 |
| 83 | MP0003828_pulmonary_edema | 0.80431720 |
| 84 | MP0002009_preneoplasia | 0.80265029 |
| 85 | MP0000015_abnormal_ear_pigmentation | 0.80147349 |
| 86 | MP0000604_amyloidosis | 0.78243286 |
| 87 | MP0003077_abnormal_cell_cycle | 0.75599589 |
| 88 | MP0003191_abnormal_cellular_cholesterol | 0.75494756 |
| 89 | MP0001663_abnormal_digestive_system | 0.73253774 |
| 90 | MP0000249_abnormal_blood_vessel | 0.71406318 |
| 91 | MP0003111_abnormal_nucleus_morphology | 0.69448431 |
| 92 | MP0000569_abnormal_digit_pigmentation | 0.68974787 |
| 93 | MP0002877_abnormal_melanocyte_morpholog | 0.67962538 |
| 94 | MP0003656_abnormal_erythrocyte_physiolo | 0.67301904 |
| 95 | MP0005390_skeleton_phenotype | 0.64426258 |
| 96 | MP0000371_diluted_coat_color | 0.64419277 |
| 97 | MP0008873_increased_physiological_sensi | 0.64288818 |
| 98 | MP0006054_spinal_hemorrhage | 0.63842802 |
| 99 | MP0004130_abnormal_muscle_cell | 0.60035825 |
| 100 | MP0003638_abnormal_response/metabolism_ | 0.54665508 |
| 101 | MP0004147_increased_porphyrin_level | 0.53378194 |
| 102 | MP0002693_abnormal_pancreas_physiology | 0.52693005 |
| 103 | MP0003566_abnormal_cell_adhesion | 0.52644058 |
| 104 | MP0003795_abnormal_bone_structure | 0.52587456 |
| 105 | MP0000313_abnormal_cell_death | 0.52294702 |
| 106 | MP0005451_abnormal_body_composition | 0.52121115 |
| 107 | MP0002136_abnormal_kidney_physiology | 0.51729579 |
| 108 | MP0008874_decreased_physiological_sensi | 0.50748354 |
| 109 | MP0009765_abnormal_xenobiotic_induced | 0.50085930 |
| 110 | MP0004484_altered_response_of | 0.49145916 |
| 111 | MP0005084_abnormal_gallbladder_morpholo | 0.48942441 |
| 112 | MP0004957_abnormal_blastocyst_morpholog | 0.48901379 |
| 113 | MP0002138_abnormal_hepatobiliary_system | 0.48009633 |
| 114 | MP0005319_abnormal_enzyme/_coenzyme | 0.47943813 |
| 115 | MP0005083_abnormal_biliary_tract | 0.47903410 |
| 116 | MP0004883_abnormal_blood_vessel | 0.47692915 |
| 117 | MP0000477_abnormal_intestine_morphology | 0.47434423 |
| 118 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.46927786 |
| 119 | MP0003252_abnormal_bile_duct | 0.46532694 |
| 120 | MP0002928_abnormal_bile_duct | 0.45209529 |
| 121 | MP0005381_digestive/alimentary_phenotyp | 0.43490275 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.88081829 |
| 2 | Myositis (HP:0100614) | 5.58186724 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.39780582 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 4.94607031 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.76512088 |
| 6 | Chronic otitis media (HP:0000389) | 4.58671654 |
| 7 | Orchitis (HP:0100796) | 4.40467901 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 4.31831591 |
| 9 | Optic neuritis (HP:0100653) | 4.31831591 |
| 10 | IgM deficiency (HP:0002850) | 4.08277140 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 4.06952532 |
| 12 | Meningitis (HP:0001287) | 4.04276344 |
| 13 | Recurrent fungal infections (HP:0002841) | 3.89952307 |
| 14 | Recurrent viral infections (HP:0004429) | 3.85270144 |
| 15 | Panhypogammaglobulinemia (HP:0003139) | 3.80371260 |
| 16 | Obstructive lung disease (HP:0006536) | 3.78657840 |
| 17 | Chronic obstructive pulmonary disease (HP:0006510) | 3.78657840 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.69515001 |
| 19 | Abnormality of macrophages (HP:0004311) | 3.60229674 |
| 20 | Encephalitis (HP:0002383) | 3.47810928 |
| 21 | Recurrent skin infections (HP:0001581) | 3.47203939 |
| 22 | Nasal polyposis (HP:0100582) | 3.42350013 |
| 23 | Thrombocytosis (HP:0001894) | 3.29573806 |
| 24 | Cellulitis (HP:0100658) | 3.22983092 |
| 25 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.21036180 |
| 26 | Keratoconjunctivitis sicca (HP:0001097) | 3.18810952 |
| 27 | Increased IgM level (HP:0003496) | 3.16439880 |
| 28 | Recurrent cutaneous fungal infections (HP:0011370) | 3.11839607 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.11839607 |
| 30 | Recurrent bronchitis (HP:0002837) | 3.07460943 |
| 31 | Colitis (HP:0002583) | 3.03301254 |
| 32 | Inflammation of the large intestine (HP:0002037) | 3.02854141 |
| 33 | Petechiae (HP:0000967) | 3.01645855 |
| 34 | Vasculitis (HP:0002633) | 2.98366800 |
| 35 | Abnormality of the prostate (HP:0008775) | 2.96570066 |
| 36 | Abnormality of the nasal mucosa (HP:0000433) | 2.95180449 |
| 37 | Reticulocytopenia (HP:0001896) | 2.93616167 |
| 38 | Agammaglobulinemia (HP:0004432) | 2.93361246 |
| 39 | Keratoconjunctivitis (HP:0001096) | 2.92887068 |
| 40 | Fatigue (HP:0012378) | 2.91905827 |
| 41 | Gastrointestinal inflammation (HP:0004386) | 2.87693905 |
| 42 | Arterial thrombosis (HP:0004420) | 2.81719650 |
| 43 | Autoimmune hemolytic anemia (HP:0001890) | 2.81707298 |
| 44 | Pulmonary infiltrates (HP:0002113) | 2.79793773 |
| 45 | Thyroiditis (HP:0100646) | 2.79721458 |
| 46 | Abnormality of T cells (HP:0002843) | 2.79676394 |
| 47 | Interstitial pulmonary disease (HP:0006530) | 2.76511504 |
| 48 | T lymphocytopenia (HP:0005403) | 2.69311573 |
| 49 | Abnormality of T cell physiology (HP:0011840) | 2.68484754 |
| 50 | Hemoptysis (HP:0002105) | 2.68038019 |
| 51 | Stomatitis (HP:0010280) | 2.67269423 |
| 52 | Gingivitis (HP:0000230) | 2.65895837 |
| 53 | Vacuolated lymphocytes (HP:0001922) | 2.61586103 |
| 54 | Gastrointestinal infarctions (HP:0005244) | 2.61520653 |
| 55 | Purpura (HP:0000979) | 2.55827295 |
| 56 | B lymphocytopenia (HP:0010976) | 2.54364319 |
| 57 | Abnormality of B cell number (HP:0010975) | 2.54364319 |
| 58 | Abnormality of T cell number (HP:0011839) | 2.54078008 |
| 59 | Episodic fever (HP:0001954) | 2.52986490 |
| 60 | Systemic lupus erythematosus (HP:0002725) | 2.51483867 |
| 61 | Pustule (HP:0200039) | 2.50442993 |
| 62 | Hypergammaglobulinemia (HP:0010702) | 2.49727604 |
| 63 | Leukocytosis (HP:0001974) | 2.43944690 |
| 64 | Prolonged bleeding time (HP:0003010) | 2.39830706 |
| 65 | Increased serum ferritin (HP:0003281) | 2.39100064 |
| 66 | Spontaneous hematomas (HP:0007420) | 2.38082382 |
| 67 | Papilledema (HP:0001085) | 2.36410272 |
| 68 | Abnormality of the pleura (HP:0002103) | 2.34589193 |
| 69 | Viral hepatitis (HP:0006562) | 2.34496650 |
| 70 | Hypochromic anemia (HP:0001931) | 2.33179213 |
| 71 | Acute hepatic failure (HP:0006554) | 2.32466694 |
| 72 | Aplastic anemia (HP:0001915) | 2.31797483 |
| 73 | Chromsome breakage (HP:0040012) | 2.30891392 |
| 74 | Abnormal platelet volume (HP:0011876) | 2.28974105 |
| 75 | Lymphopenia (HP:0001888) | 2.27791987 |
| 76 | Abnormality of iron homeostasis (HP:0011031) | 2.27640448 |
| 77 | Severe combined immunodeficiency (HP:0004430) | 2.27017102 |
| 78 | Epistaxis (HP:0000421) | 2.25702496 |
| 79 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.25185568 |
| 80 | Lymphoma (HP:0002665) | 2.24667024 |
| 81 | Amaurosis fugax (HP:0100576) | 2.22248888 |
| 82 | Increased cerebral lipofuscin (HP:0011813) | 2.20611506 |
| 83 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.19914777 |
| 84 | Loss of speech (HP:0002371) | 2.19799397 |
| 85 | Eosinophilia (HP:0001880) | 2.19369026 |
| 86 | Periodontitis (HP:0000704) | 2.18956106 |
| 87 | Osteomyelitis (HP:0002754) | 2.18828408 |
| 88 | Increased IgE level (HP:0003212) | 2.17398705 |
| 89 | Acute myeloid leukemia (HP:0004808) | 2.16439668 |
| 90 | Vertigo (HP:0002321) | 2.16347885 |
| 91 | Hypochromic microcytic anemia (HP:0004840) | 2.16306852 |
| 92 | Autoimmune thrombocytopenia (HP:0001973) | 2.16229892 |
| 93 | Combined immunodeficiency (HP:0005387) | 2.15457932 |
| 94 | Gingival bleeding (HP:0000225) | 2.15325212 |
| 95 | Chest pain (HP:0100749) | 2.13450977 |
| 96 | Chronic diarrhea (HP:0002028) | 2.12903914 |
| 97 | Dysostosis multiplex (HP:0000943) | 2.11133401 |
| 98 | Pulmonary embolism (HP:0002204) | 2.11011861 |
| 99 | Granulocytopenia (HP:0001913) | 2.10082745 |
| 100 | Gangrene (HP:0100758) | 2.09933384 |
| 101 | Anorexia (HP:0002039) | 2.08548540 |
| 102 | Urticaria (HP:0001025) | 2.08256170 |
| 103 | Impaired platelet aggregation (HP:0003540) | 2.04748783 |
| 104 | Abnormal platelet function (HP:0011869) | 2.04748783 |
| 105 | Reduced antithrombin III activity (HP:0001976) | 2.04661557 |
| 106 | IgG deficiency (HP:0004315) | 2.04496777 |
| 107 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.02337429 |
| 108 | Thrombophlebitis (HP:0004418) | 2.01712128 |
| 109 | Abnormality of eosinophils (HP:0001879) | 2.00833453 |
| 110 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.00076549 |
| 111 | Glomerulopathy (HP:0100820) | 1.99438524 |
| 112 | Abnormality of DNA repair (HP:0003254) | 1.99158584 |
| 113 | Sepsis (HP:0100806) | 1.98855981 |
| 114 | Hypoproteinemia (HP:0003075) | 1.98269835 |
| 115 | Skin ulcer (HP:0200042) | 1.98234758 |
| 116 | Hypoplasia of the thymus (HP:0000778) | 1.97476839 |
| 117 | Amyloidosis (HP:0011034) | 1.96861957 |
| 118 | Peritonitis (HP:0002586) | 1.94697758 |
| 119 | Abnormality of the fingertips (HP:0001211) | 1.94304900 |
| 120 | Chronic sinusitis (HP:0011109) | 1.93718439 |
| 121 | Papilloma (HP:0012740) | 1.93440766 |
| 122 | Verrucae (HP:0200043) | 1.93440766 |
| 123 | Recurrent pneumonia (HP:0006532) | 1.93190368 |
| 124 | Joint swelling (HP:0001386) | 1.92710254 |
| 125 | Skin rash (HP:0000988) | 1.91504629 |
| 126 | Keratitis (HP:0000491) | 1.90860534 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.45720272 |
| 2 | KIT | 3.80149481 |
| 3 | TXK | 3.36158101 |
| 4 | FLT3 | 3.14161012 |
| 5 | BLK | 2.99456482 |
| 6 | TAOK3 | 2.91377535 |
| 7 | IRAK4 | 2.86808755 |
| 8 | TEC | 2.68418927 |
| 9 | CSF1R | 2.41741825 |
| 10 | BTK | 2.30727274 |
| 11 | PRPF4B | 2.24658027 |
| 12 | TBK1 | 2.14980085 |
| 13 | EEF2K | 2.00325337 |
| 14 | FES | 2.00097751 |
| 15 | TYK2 | 1.98449378 |
| 16 | ITK | 1.97981057 |
| 17 | SYK | 1.85386719 |
| 18 | IRAK3 | 1.78775494 |
| 19 | STK10 | 1.77557491 |
| 20 | ZAP70 | 1.76737473 |
| 21 | MAP3K14 | 1.70255418 |
| 22 | CLK1 | 1.60109028 |
| 23 | SCYL2 | 1.58980762 |
| 24 | JAK3 | 1.57904020 |
| 25 | MAP2K3 | 1.57284151 |
| 26 | RIPK4 | 1.57026675 |
| 27 | BMPR2 | 1.50898936 |
| 28 | JAK1 | 1.40399170 |
| 29 | PIM2 | 1.38396798 |
| 30 | CSK | 1.33303533 |
| 31 | PIM1 | 1.31831461 |
| 32 | TGFBR2 | 1.31253376 |
| 33 | LCK | 1.30847649 |
| 34 | GRK6 | 1.29785028 |
| 35 | LYN | 1.28512844 |
| 36 | ERN1 | 1.28331277 |
| 37 | ACVR1B | 1.27506390 |
| 38 | IKBKE | 1.27032564 |
| 39 | IKBKB | 1.25792729 |
| 40 | LRRK2 | 1.23754971 |
| 41 | HCK | 1.15165474 |
| 42 | MATK | 1.09240467 |
| 43 | CCNB1 | 1.06329577 |
| 44 | MAP3K1 | 1.05755992 |
| 45 | PKN2 | 1.03803668 |
| 46 | MST4 | 1.03105534 |
| 47 | BRSK2 | 1.02046970 |
| 48 | MAP3K3 | 0.99198649 |
| 49 | NME2 | 0.96957962 |
| 50 | RPS6KA4 | 0.96493691 |
| 51 | SIK3 | 0.95011725 |
| 52 | TRPM7 | 0.93964765 |
| 53 | TESK2 | 0.93119872 |
| 54 | VRK1 | 0.89781856 |
| 55 | MAP3K12 | 0.84756523 |
| 56 | STK16 | 0.82741245 |
| 57 | MAPKAPK3 | 0.80560144 |
| 58 | TGFBR1 | 0.78745548 |
| 59 | NLK | 0.78147183 |
| 60 | TAOK1 | 0.77915446 |
| 61 | MAP3K7 | 0.74203712 |
| 62 | EIF2AK3 | 0.73688378 |
| 63 | ADRBK2 | 0.73372957 |
| 64 | PASK | 0.73329765 |
| 65 | RPS6KB2 | 0.70749483 |
| 66 | PTK2B | 0.70343024 |
| 67 | GRK7 | 0.70155794 |
| 68 | EIF2AK1 | 0.69888222 |
| 69 | FYN | 0.69339609 |
| 70 | EPHB1 | 0.68863229 |
| 71 | CDC7 | 0.68673960 |
| 72 | BCKDK | 0.67960014 |
| 73 | MARK2 | 0.67077516 |
| 74 | CDK4 | 0.66943860 |
| 75 | IRAK1 | 0.66704851 |
| 76 | MARK3 | 0.65501435 |
| 77 | TNIK | 0.64601603 |
| 78 | MAPK7 | 0.62709883 |
| 79 | EIF2AK2 | 0.61673739 |
| 80 | WEE1 | 0.60278849 |
| 81 | HIPK2 | 0.60272674 |
| 82 | PDPK1 | 0.59341676 |
| 83 | MAPK12 | 0.57850688 |
| 84 | MAP2K6 | 0.57297318 |
| 85 | JAK2 | 0.56283441 |
| 86 | MAP3K10 | 0.56277879 |
| 87 | CHUK | 0.55741706 |
| 88 | STK11 | 0.55153408 |
| 89 | KDR | 0.54832261 |
| 90 | CAMKK1 | 0.54554906 |
| 91 | PRKD2 | 0.52742683 |
| 92 | NEK9 | 0.52575040 |
| 93 | CDK19 | 0.51923958 |
| 94 | ATR | 0.47602621 |
| 95 | DYRK1B | 0.47538821 |
| 96 | MAPK4 | 0.47508473 |
| 97 | MAP3K6 | 0.46812297 |
| 98 | MAP3K5 | 0.46423995 |
| 99 | MAP2K2 | 0.46333902 |
| 100 | MAP3K11 | 0.44704625 |
| 101 | STK4 | 0.44360871 |
| 102 | MAPKAPK2 | 0.44067846 |
| 103 | CDK7 | 0.43334095 |
| 104 | TAOK2 | 0.42154118 |
| 105 | RPS6KA6 | 0.41965938 |
| 106 | IRAK2 | 0.40352296 |
| 107 | FGR | 0.40068080 |
| 108 | CDK6 | 0.39650682 |
| 109 | KSR2 | 0.39154919 |
| 110 | PRKCD | 0.37369299 |
| 111 | FGFR3 | 0.36449780 |
| 112 | YES1 | 0.36285549 |
| 113 | MAP3K13 | 0.36208729 |
| 114 | TNK2 | 0.35955095 |
| 115 | MAP3K8 | 0.34992307 |
| 116 | PTK6 | 0.34921606 |
| 117 | PIK3CG | 0.33167304 |
| 118 | BRSK1 | 0.33064068 |
| 119 | RPS6KC1 | 0.32211646 |
| 120 | RPS6KL1 | 0.32211646 |
| 121 | MAPKAPK5 | 0.31851006 |
| 122 | PDK1 | 0.30243867 |
| 123 | CDK8 | 0.29849024 |
| 124 | NEK2 | 0.29592867 |
| 125 | TRIB3 | 0.29263326 |
| 126 | CAMKK2 | 0.28988417 |
| 127 | PRKCQ | 0.28567291 |
| 128 | NUAK1 | 0.28486462 |
| 129 | SIK2 | 0.27997571 |
| 130 | ABL1 | 0.27479953 |
| 131 | PRKCH | 0.27071250 |
| 132 | IGF1R | 0.26993739 |
| 133 | PAK4 | 0.26620597 |
| 134 | WNK1 | 0.26469566 |
| 135 | MOS | 0.24692912 |
| 136 | RET | 0.24310831 |
| 137 | MAPK3 | 0.23572386 |
| 138 | GRK5 | 0.22573122 |
| 139 | MAPK11 | 0.22207795 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.28960550 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.04535474 |
| 3 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.87580787 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.81013348 |
| 5 | DNA replication_Homo sapiens_hsa03030 | 2.74485034 |
| 6 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.66907684 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.39317428 |
| 8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.24513666 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.16155781 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.12210815 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.11946536 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.09443523 |
| 13 | Measles_Homo sapiens_hsa05162 | 2.07476646 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.01609263 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 1.96943195 |
| 16 | Ribosome_Homo sapiens_hsa03010 | 1.90750848 |
| 17 | Other glycan degradation_Homo sapiens_hsa00511 | 1.90542036 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 1.87205353 |
| 19 | Legionellosis_Homo sapiens_hsa05134 | 1.79805805 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.71390225 |
| 21 | Malaria_Homo sapiens_hsa05144 | 1.70554932 |
| 22 | Mismatch repair_Homo sapiens_hsa03430 | 1.65063480 |
| 23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.62013375 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.60835259 |
| 25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.59567258 |
| 26 | Base excision repair_Homo sapiens_hsa03410 | 1.56874963 |
| 27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.56774953 |
| 28 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.46313685 |
| 29 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.44708275 |
| 30 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.41456944 |
| 31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.41311763 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.36072330 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.35829110 |
| 34 | Homologous recombination_Homo sapiens_hsa03440 | 1.33269167 |
| 35 | Apoptosis_Homo sapiens_hsa04210 | 1.31491300 |
| 36 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.30519753 |
| 37 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.30512853 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.30154417 |
| 39 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.29672997 |
| 40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.26158232 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.25308441 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.24152404 |
| 43 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.23130589 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.18867122 |
| 45 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.18700824 |
| 46 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.18543891 |
| 47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.14743667 |
| 48 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.01919965 |
| 49 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.01918789 |
| 50 | Platelet activation_Homo sapiens_hsa04611 | 1.01176036 |
| 51 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.00874057 |
| 52 | Salmonella infection_Homo sapiens_hsa05132 | 0.98505610 |
| 53 | Lysosome_Homo sapiens_hsa04142 | 0.98224187 |
| 54 | Asthma_Homo sapiens_hsa05310 | 0.97363178 |
| 55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.96251761 |
| 56 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.90870294 |
| 57 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.88679385 |
| 58 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.83402726 |
| 59 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.82140908 |
| 60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.80381669 |
| 61 | Spliceosome_Homo sapiens_hsa03040 | 0.79814530 |
| 62 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.79341974 |
| 63 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.74700473 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.74620045 |
| 65 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.73790028 |
| 66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.72883962 |
| 67 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.69099787 |
| 68 | Phagosome_Homo sapiens_hsa04145 | 0.68577365 |
| 69 | Cell cycle_Homo sapiens_hsa04110 | 0.68510958 |
| 70 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64804895 |
| 71 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.64322059 |
| 72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63734295 |
| 73 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.62567445 |
| 74 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.62404450 |
| 75 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.62376718 |
| 76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61963525 |
| 77 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.61803649 |
| 78 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60595995 |
| 79 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58382177 |
| 80 | Hepatitis C_Homo sapiens_hsa05160 | 0.56511820 |
| 81 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55727083 |
| 82 | RNA degradation_Homo sapiens_hsa03018 | 0.55401732 |
| 83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52729665 |
| 84 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.52719069 |
| 85 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.52161605 |
| 86 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.52047027 |
| 87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52028280 |
| 88 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.49805768 |
| 89 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.48642105 |
| 90 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48507577 |
| 91 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.48457866 |
| 92 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47127897 |
| 93 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46599332 |
| 94 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.46358238 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.44736896 |
| 96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44585900 |
| 97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43705148 |
| 98 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43287731 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42818522 |
| 100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42560024 |
| 101 | Colorectal cancer_Homo sapiens_hsa05210 | 0.41684335 |
| 102 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.39853461 |
| 103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.38732633 |
| 104 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38608240 |
| 105 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.38243486 |
| 106 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.37474512 |
| 107 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.36905562 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.36257075 |
| 109 | Amoebiasis_Homo sapiens_hsa05146 | 0.35847828 |
| 110 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.35619092 |
| 111 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.35470522 |
| 112 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35258303 |
| 113 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.32766181 |
| 114 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32438405 |
| 115 | Proteasome_Homo sapiens_hsa03050 | 0.31787344 |
| 116 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31602293 |
| 117 | Insulin resistance_Homo sapiens_hsa04931 | 0.30524902 |
| 118 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.30194311 |
| 119 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.28705322 |
| 120 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.27585201 |
| 121 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.27480177 |
| 122 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.25784546 |
| 123 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.25111686 |
| 124 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.24452130 |
| 125 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.22834078 |
| 126 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.22200922 |
| 127 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.19082513 |
| 128 | Endometrial cancer_Homo sapiens_hsa05213 | 0.18208796 |
| 129 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.16078745 |

